Blog

That’s a lot of 6’s, but this author argues that despite passing the 6 billion mark, population is not a problem. He writes, “the world’s population will soon peak, and then plummet downward at an ever-increasing rate. Many countries have

At last week’s UCLA Technology & Aging Conference, representatives from Intel, Microsoft, Qualcomm, Toyota and other big-name firms discussed how technology is reshaping lifestyles for older individuals. However, important policy implications directly connected to these new tools went unspoken. RFID

This is an interesting column by David Brooks (NYT registration required). He argues that because of the current scientific revolution, a cultural effect will take place in religious circles, but not the one you expect. Everyone expects to see the

From the UK Times: “THE British doctor who pioneered test-tube babies has forecast that within decades stem-cell technology will make it possible to grow replacements for virtually any part of the human body. Robert Edwards, 82, said the emerging field

Here is an interesting post from my friend Auren Hoffman on Coke’s inability to do math.

Here’s an interesting article in the SF Chronicle about medical tourism. According to the article, ” No official statistics are kept on how many Americans travel overseas for medical care, but one estimate places the number at 150,000 in 2006.”

Last week, GlaxoSmithKline announced it will buy Sirtris Pharmaceuticals for US$720 million, giving weight to the claim that antiaging biotech firms can be a good bet. This is good news for Americans, given that a recent Harvard-affiliated study showed that

Here is a recent Congressional Budget Office report on how wealth and education are linked to life expectancy.

While life expectancy is going up overall, there are some areas of the US where it has actually decreased. It is difficult to pinpoint a single reason, but regions affected include the deep south, along the Mississippi river, in Appalachia,

This is good news, not only for those with the Leber’s Congenital Amaurosis disease, but also for the entire field of gene therapy which had suffered setbacks when a a teenager named Jesse Gelsinger died of organ failure just days